PATH | VRL
Menu

Immune Response to Type III Group B Streptococcal Polysaccharide-Tetanus Toxoid Conjugate Vaccine

This article, published in The Journal of Clinical Investigation, reports the results of a study that examined a capsular polysaccharide-protein conjugate vaccine against group B Streptococccus. The authors found that the vaccine candidate was well-tolerated and resulted in increased antibodies against the disease. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)

Author: Kasper DL, Paoletti LC, Wessels MR, et al.

Published: 1996

» Visit web page (English)

(Located at www.jci.org)

Citation: Kasper DL, Paoletti LC, Wessels MR, et al. Immune Response to Type III Group B Streptococcal Polysaccharide-Tetanus Toxoid Conjugate Vaccine. The Journal of Clinical Investigation. 1996;98(10):2308-2314.

Resource types: Peer-reviewed journal

Diseases/vaccines: Group B Streptococcus (GBS)

Topics: Vaccine safety and performance, Disease/vaccine specific information

Regions: Global